What is the main business of Naturgreen?

The main business activity of Naturgreen focuses on manufacture of basic pharmaceutical products.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on July 6, 2012.

Where is the headquarters located?

The headquarters is located at: ul. Leszno 8, 01-192 Warszawa.

Who is on the management board?

The management board consists of: Ewa Róża Olszowska (Member of the Management Board).

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2019 to December 31, 2019.

What was the revenue?

The company reported a revenue of $34,949 in 2019, which is a decrease of 35.3% compared to 2018.

No, the company recorded a net loss of $3,388 in 2019. For comparison, in 2018 the loss was $1,827, meaning the company increased its loss by 97.1%.

What is the main operating cost?

The largest operating cost category falls under materials and energy. This category amounted to $2,213 in 2019, representing 6% of all operating expenses.

Naturgreensp. z o.o.

Manufacture of basic pharmaceutical products

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2012-07-06

Share capital

5,000.00 PLN

Registered address

ul. Leszno 8/63, 01-192 Warszawa, Poland

Electronic delivery address

AE:PL-73773-26288-HFFUE-38

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2020 – the filing deadline has passed. 2 of 2 financial statements were filed late (the longest delay 654 days for 2018).

2020not filed
201929/04/2021
201829/04/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2019.

Results vs industry

Revenue

This companyUSD 34.95kMedianUSD 164.14kAverageUSD 2.27m

Net profit

This companyUSD -3.39kMedianUSD 1.03kAverageUSD 108.21k

Operating costs

This companyUSD 36.77kMedianUSD 187.05kAverageUSD 2.07m

Assets

This companyUSD 29.98kMedianUSD 115.76kAverageUSD 1.52m

Industry

Authorized Representatives

Ewa Róża Olszowska – Management Board Member

Manner of representation

In the case of a multi-member management board, the joint action of at least two members of the management board or of a member of the management board and a commercial proxy is required to make declarations on behalf of the company. In the case of a one-person management board, the sole member of the management board is independently authorised to make declarations on behalf of the company.

Ownership

Owner	Shares	Share value	Stake
Agnieszka Magdalena Krzysztońage 54	30	$405.19	30%
Ewa Róża Olszowskaage 37	70	$945.43	70%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2012-09-05.

No bank accounts reported to the VAT Taxpayer Register.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Natur DayS.A.	$680,635.59	naturday.pl
Biotriosp. z o.o.	$453,662.22	biotrio.pl
Nature's Voicesp. z o.o.	$181,977.76	naturesvoice.eu
Pexon Polandsp. z o.o.	$122,615.96	pexon.pl
Munar PharmaS.A.	$85,649.72	munar.pl
Bioresearch PharmaS.A.	$21,432.15	bioresearchpharma.com
Sanford Biotechsp. z o.o.	$2,586.64	sanfordbiotech.com
Cefeasp. z o.o.	$294.66	cefea.pl
Auxilius PharmaS.A.	$0.83	auxiliuspharma.com
Grupa FinepharmS.A.	–	finepharm.pl

Change history

Date	Event
2020-09-02	Address change (Górczewska 253d/8, 01-459, Warszawa → Ul. Leszno 8/63, 01-192, Warszawa)
2016-03-31	PKD change (Removed: 11 codes)
2012-10-08	Address change (Szczęśliwicka 68/1a, 02-353, Warszawa → Górczewska 253d/8, 01-459, Warszawa)
2012-07-06	Entered in the register

FAQ

Last updated: 2026-04-23